(Q57694020)
Statements
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours (English)
S Blagden
A L Thomas
E Scott
R Molife
L Vidal
S Pacey
D Sarkar
A Jenner
J S De-Bono